CollPlant Biotechnologies (CollPlant Biotechnologies) Change In Receivables : $0.21 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is CollPlant Biotechnologies Change In Receivables?

CollPlant Biotechnologies's change in receivables for the quarter that ended in Mar. 2024 was $0.02 Mil. It means CollPlant Biotechnologies's Accounts Receivable declined by $0.02 Mil from Dec. 2023 to Mar. 2024 .

CollPlant Biotechnologies's change in receivables for the fiscal year that ended in Dec. 2023 was $0.01 Mil. It means CollPlant Biotechnologies's Accounts Receivable declined by $0.01 Mil from Dec. 2022 to Dec. 2023 .

CollPlant Biotechnologies's Accounts Receivable for the quarter that ended in Mar. 2024 was $0.09 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. CollPlant Biotechnologies's Days Sales Outstanding for the three months ended in Mar. 2024 was 83.80.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. CollPlant Biotechnologies's liquidation value for the three months ended in Mar. 2024 was $17.77 Mil.

CollPlant Biotechnologies Change In Receivables Historical Data

The historical data trend for CollPlant Biotechnologies's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CollPlant Biotechnologies Change In Receivables Chart

CollPlant Biotechnologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

0.47

-0.72

0.56

0.26

0.01

CollPlant Biotechnologies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-0.18	-10.19	10.42	-0.05	0.02

CollPlant Biotechnologies Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.21 Mil.

CollPlant Biotechnologies (NAS:CLGN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

CollPlant Biotechnologies's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.09	/	0.098	*	91
=	83.80

2. In Ben Graham's calculation of liquidation value, CollPlant Biotechnologies's accounts receivable are only considered to be worth 75% of book value:

CollPlant Biotechnologies's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	23.225	-	5.846	+	0.75 * 0.09	+	0.5 * 0.645
=	17.77

CollPlant Biotechnologies Change In Receivables Related Terms

Thank you for viewing the detailed overview of CollPlant Biotechnologies's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

CollPlant Biotechnologies (CollPlant Biotechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CollPlant Biotechnologies Ltd (NAS:CLGN) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

CPT:Germany

Address

4 Oppenheimer Street, P.O. Box 4132, Weizmann Science Park, Rehovot, ISR, 7670104

Website

https://www.collplant.com

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The company's revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing.